Choosing Between Novel Agents and Chemoimmunotherapy in CLL

  H&O  Which novel agents are available for physicians treating patients with chronic lymphocytic leukemia?  JW  Right now, we have Bruton tyrosine kinase (BTK) inhibitors, phosphoinositide-3 […]